NEW MJ NEWS

AbbVie to Present at the Wolfe Research Healthcare Conference

AbbVie (NYSE: ABBV) will participate in the Wolfe Research Healthcare Conference on Wednesday, November 17, 2021. Michael Severino, M.D., vice chairman and president, Robert A. Michael, executive vice president and chief financial officer, and Jeffrey R. Stewart, executive vice president, commercial operations, will present at 8:30 a.m. Central time.

A live audio webcast of the presentation will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie
AbbVie’s mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience, eye care, virology, women’s health and gastroenterology, in addition to products and services across its Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on Twitter, Facebook, Instagram, YouTube and LinkedIn.

View original content:https://www.prnewswire.com/news-releases/abbvie-to-present-at-the-wolfe-research-healthcare-conference-301420573.html

SOURCE AbbVie


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

$PMCB Awaits Pivotal U.S. Study Results Expected to Lead to Human Clinical Trials

PharmaCyte Biotech Awaits Pivotal U.S. Study Results Expected to Lead to Human…

$LXRP Announces Million Dollar Research and Development Program

Lexaria Announces Million Dollar Research and Development Program Lexaria Bioscience Corp (LXRP)(CSE:LXX)(LXX.CN)(CNSX:LXX)…

Lexaria Bioscience Corp. (LXRP) Files Innovative New Patent Application

Lexaria Bioscience Files Innovative New Patent Application Lexaria Bioscience Corp. (LXRP) (CSE:LXX)…

Canopy Growth Corporation (CGC) Expands Premium Flower Portfolio with New Offerings

Canopy Growth Expands Premium Flower Portfolio with New Offerings across 7ACRES, 7ACRES…